Prime Minister, Tuilaepa Dr. Sa’ilele Malielegaoi, has slammed the door on a proposal by an Australia-primarily based enterprise for Samoa to appear into the cultivation and production of cannabis for medicinal purposes.
The proposal was produced by a enterprise named Leaf Relief primarily based in Australia.
The Samoa Observer understands that the enterprise wanted to negotiate with the Government about the possibilities for Samoa to cultivate cannabis with an eye on the international market place.
But Tuilaepa, in a letter addressed to Reynard Muliaina of Leaf Relief, dated 11 April 2019, booted the notion to touch.
Tuilaepa informed Mr. Muliaina the notion of cultivating cannabis for medicinal purposes will not materialise in Samoa.
“Your project proposal for cannabis cultivation has been completely analyzed by our officials,” Tuilaepa writes.
“Its conclusion is for Government to reject outright the cultivation of cannabis in Samoa. It may possibly be 200 years however just before we shall ever once more look at this sort of project for our peaceful Samoa.”
Attempts by the Samoa Observer to speak to Mr. Muliaina for a comment had been unsuccessful. Contacted, his father stated he has left the county.
An e-mail sent to Mr. Muliaina has not been responded to by press time.
It is not the initial time medicinal marijuana has surfaced in Samoa.
The notion was raised and strongly debated a couple of years ago with advocates calling on the Government to legalise cannabis to permit the Court to concentrate on other criminal matters.
Most lately, the Immigration Workplace refused to look at a proposal to permit international travellers to carry controlled drugs – if they are legally prescribed by an authorised particular person – from their property nations.
In 2017, the Samoa Law Reform Commission (S.L.R.C.) in their Drug Reform report, suggested the new drugs framework need to involve a provision exempting international travellers, who have been authorised to carry illegal drugs for remedy when getting into Samoa, equivalent to Tonga and New Zealand.
“However, strict recommendations and situations need to have to be in spot to regulate such practice which may possibly involve the following:
– the quantity to be permitted into Samoa which need to be significantly less than a month provide i.e. 30 day permit the drug was lawfully supplied in nation of origin for a specific healthcare situation and that it was authorized by an authorised healthcare practitioner and- as proof, appropriate healthcare documentation/ proof such as a healthcare report should be offered certifying that the controlled drug is prescribed for remedy.”